Identification of a potent and selective phosphatidylinositol 3-kinase δ inhibitor for the treatment of non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of a potent and selective phosphatidylinositol 3-kinase δ inhibitor for the treatment of non-Hodgkin's lymphoma

Published:2020-12 Issue: Volume:105 Page:104344
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Zuo Wei-Qiong,Hu Rong,Wang Wan-Li,Zhu Yong-Xia,Xu Ying,Yu Luo-Ting,Liu Zhi-Hao,Wang Ning-Yu

Funder

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference33 articles.

1. The phosphoinositide 3-kinase pathway;Cantley;Science,2002

2. SnapShot: class I PI3K isoform signaling;Fritsch;Cell,2013

3. p110δ, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes;Chantry;J. Biol. Chem.,1997

4. p110δ, a novel phosphoinositide 3-kinase in leukocytes;Vanhaesebroeck;Proc. Natl. Acad. Sci. USA,1997

5. Essential, nonredundant role for the phosphoinositide 3-kinase p110δ in signaling by the B-cell receptor complex;Jou;Mol. Cell Biol.,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential;Archiv der Pharmazie;2024-05-16

2. Optimization of virtual screening against phosphoinositide 3-kinase delta: Integration of common feature pharmacophore and multicomplex-based molecular docking;Computational Biology and Chemistry;2024-04

3. Design, synthesis and biological evaluation of novel 9-methyl-9H-purine and thieno[3, 2-d]pyrimidine derivatives as potent mTOR inhibitors;Bioorganic Chemistry;2023-03

4. Targeting MYC-driven lymphoma: lessons learned and future directions;Cancer Drug Resistance;2023

5. Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions;Journal of Medicinal Chemistry;2022-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3